Assessing the role of ADAM10 in Trastuzumab treatment and resistance
<p>Overexpression of the HER2 receptor occurs in about 15-20% of all breast cancers and is correlated with poor prognosis. Trastuzumab (Herceptin®), a monoclonal antibody targeting HER2, was shown to prolong survival of these patients. However, primary or acquired resistance remains a drawback...
第一著者: | Feldinger, K |
---|---|
その他の著者: | Kong, A |
フォーマット: | 学位論文 |
言語: | English |
出版事項: |
2012
|
主題: |
類似資料
-
Functional organisation of the Hrd1 ubiquitin ligase complex and its role in ERAD
著者:: Schulz, J
出版事項: (2013) -
The role and regulation of Asterless in the centrosome cycle
著者:: Novak, ZA
出版事項: (2014) -
Characterisation of AEBP2: a polycomb repressive complex 2 component
著者:: Grijzenhout, A
出版事項: (2013) -
Cell stress response and hypoxia in breast cancer
著者:: Milani, M, 等
出版事項: (2011) -
Nitric oxide: a chemical effector of pathogenesis in magnaporthe oryzae
著者:: Johnson, J
出版事項: (2011)